Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1311618.RAB-H74it1JAkmMEYMxNLjIHUh7kGZGbGOiKsy6ytBncM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1311618.RAB-H74it1JAkmMEYMxNLjIHUh7kGZGbGOiKsy6ytBncM130_assertion type Assertion NP1311618.RAB-H74it1JAkmMEYMxNLjIHUh7kGZGbGOiKsy6ytBncM130_head.
- NP1311618.RAB-H74it1JAkmMEYMxNLjIHUh7kGZGbGOiKsy6ytBncM130_assertion description "[For somatic gene therapy to become a realistic therapeutic strategy for chronic granulomatous disease (CGD), we have to be able to assign the molecular lesion to a specific component of the NADPH oxidase and to confirm that transfer of a functional copy of the corresponding defective gene will result in correction of the cellular defect.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1311618.RAB-H74it1JAkmMEYMxNLjIHUh7kGZGbGOiKsy6ytBncM130_provenance.
- NP1311618.RAB-H74it1JAkmMEYMxNLjIHUh7kGZGbGOiKsy6ytBncM130_assertion evidence source_evidence_literature NP1311618.RAB-H74it1JAkmMEYMxNLjIHUh7kGZGbGOiKsy6ytBncM130_provenance.
- NP1311618.RAB-H74it1JAkmMEYMxNLjIHUh7kGZGbGOiKsy6ytBncM130_assertion SIO_000772 7541496 NP1311618.RAB-H74it1JAkmMEYMxNLjIHUh7kGZGbGOiKsy6ytBncM130_provenance.
- NP1311618.RAB-H74it1JAkmMEYMxNLjIHUh7kGZGbGOiKsy6ytBncM130_assertion wasDerivedFrom befree-2016 NP1311618.RAB-H74it1JAkmMEYMxNLjIHUh7kGZGbGOiKsy6ytBncM130_provenance.
- NP1311618.RAB-H74it1JAkmMEYMxNLjIHUh7kGZGbGOiKsy6ytBncM130_assertion wasGeneratedBy ECO_0000203 NP1311618.RAB-H74it1JAkmMEYMxNLjIHUh7kGZGbGOiKsy6ytBncM130_provenance.